• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

槲寄生制剂标准化研究。

Studies on the standardization of mistletoe preparations.

作者信息

Wagner H, Jordan E, Feil B

出版信息

Oncology. 1986;43 Suppl 1:16-22. doi: 10.1159/000226416.

DOI:10.1159/000226416
PMID:3027640
Abstract

The newly isolated phenylpropanoids syringin, syringenin-apiosylglucoside, eleutheroside E and the high molecular lectins and viscotoxins were selected for a standardization of mistletoe extracts and drug preparation. The phenylpropanoids found in all alcoholic and aqueous extracts were suitable for an HPLC fingerprint analysis, and for quantitative determination. The lectin content of the drug preparations was determined by single radial immunodiffusion. As shown by the isoelectric focussing method, Iscador and fermented mistletoe extracts contain only the mistletoe lectins ML II/III, whereas the proteins of the ML I complex are missing. For identification and quantitative determination of viscotoxins, an HPLC method was designed.

摘要

新分离出的苯丙素类化合物紫丁香苷、紫丁香苷 - 芹菜糖基葡萄糖苷、刺五加苷E以及高分子凝集素和槲寄生毒素被选用于槲寄生提取物和药物制剂的标准化。在所有醇提取物和水提取物中发现的苯丙素类化合物适用于高效液相色谱指纹图谱分析和定量测定。药物制剂中的凝集素含量通过单向放射免疫扩散法测定。等电聚焦法显示,Iscador和发酵槲寄生提取物仅含有槲寄生凝集素ML II/III,而ML I复合物的蛋白质缺失。为了鉴定和定量测定槲寄生毒素,设计了一种高效液相色谱法。

相似文献

1
Studies on the standardization of mistletoe preparations.槲寄生制剂标准化研究。
Oncology. 1986;43 Suppl 1:16-22. doi: 10.1159/000226416.
2
[Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].[槲寄生制剂中凝集素和槲寄生毒素的检测与定量测定]
Arzneimittelforschung. 1986 Mar;36(3):428-33.
3
Characterization of cytotoxic proteins from mistletoe (Viscum album L.).槲寄生(欧洲槲寄生)细胞毒性蛋白的特性分析。
Cancer Lett. 1990 May 30;51(2):103-8. doi: 10.1016/0304-3835(90)90044-x.
4
Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.对Iscador(一种据称具有抗癌特性的槲寄生制剂)中一种有毒凝集素的特性研究。
Oncology. 1988;45(3):172-9. doi: 10.1159/000226557.
5
Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Coloratum.从韩国槲寄生(白果槲寄生变种)中分离并鉴定具有生物活性的凝集素。
Cell Mol Life Sci. 1999 Apr;55(4):679-82. doi: 10.1007/s000180050324.
6
Mistletoe lectins and their A and B chains.槲寄生凝集素及其A链和B链。
Oncology. 1986;43 Suppl 1:23-34. doi: 10.1159/000226417.
7
Detection of isolated mistletoe lectin chains in plant extracts.检测植物提取物中分离出的槲寄生凝集素链。
Arzneimittelforschung. 2002;52(1):67-71. doi: 10.1055/s-0031-1299859.
8
Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.发酵与未发酵槲寄生制剂对培养肿瘤细胞作用的比较。
Oncology. 1986;43 Suppl 1:35-41. doi: 10.1159/000226418.
9
[Ingredients of mistletoe (Viscum album L.) as potential drugs].[槲寄生(欧洲槲寄生)作为潜在药物的成分]
Pharmazie. 1985 Feb;40(2):97-104.
10
Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.用欧洲槲寄生处理的人淋巴细胞中的细胞凋亡诱导是由槲寄生凝集素介导的。
Cancer Lett. 1996 Jan 19;99(1):59-72. doi: 10.1016/0304-3835(95)04038-2.

引用本文的文献

1
Metabolomics by UHPLC-Q-TOF Reveals Host Tree-Dependent Phytochemical Variation in L.超高效液相色谱-四极杆飞行时间质谱联用代谢组学揭示了寄主树依赖的L.植物化学变化
Plants (Basel). 2021 Aug 20;10(8):1726. doi: 10.3390/plants10081726.
2
Loranthus ferrugineus: a Mistletoe from Traditional Uses to Laboratory Bench.锈毛钝果寄生:一种从传统用途走向实验室研究的槲寄生植物
J Pharmacopuncture. 2015 Mar;18(1):7-18. doi: 10.3831/KPI.2015.18.001.
3
Effect of gamma irradiation on mistletoe (Viscum album) lectin-mediated toxicity and immunomodulatory activity.
γ 射线辐照对槲寄生(Viscum album)凝集素介导的毒性和免疫调节活性的影响。
FEBS Open Bio. 2013 Jan 22;3:106-11. doi: 10.1016/j.fob.2013.01.003. Print 2013.
4
The everlasting mistletoe and the cardiovascular system.永恒的槲寄生与心血管系统。
Tex Heart Inst J. 1990;17(4):310-4.
5
Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.癌症的非常规疗法:3. 伊斯卡多。加拿大乳腺癌研究倡议替代疗法特别工作组。
CMAJ. 1998 May 5;158(9):1157-9.